Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-08 | Dr. Mark P. SchoenbergChief Medical Officer | -5,22k | 142,56k | Derivative Exercise and Sale | 27,30 | 139,76k | - |
| 2026-06-08 | Dr. Mark P. SchoenbergChief Medical Officer | 4,78k | 0,00 | Derivative Exercise and Retained Stock | - | 139,76k | 3,54% |
| 2026-05-26 | Mr. James A. RobinsonIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 6,00k | 50,00% |
| 2026-05-08 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 300,00k | Automatic Disposition | 30,00 | 134,99k | -6,90% |
| 2025-02-26 | Mr. James A. RobinsonIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 4,00k | 100,00% |
| 2026-01-31 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | 8,02k | 0,00 | Derivative Exercise and Retained Stock | - | 55,59k | 16,86% |
| 2026-01-31 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -7,48k | 147,26k | Derivative Exercise and Sale | 19,69 | 55,59k | - |
| 2026-02-03 | Dr. Mark P. SchoenbergChief Medical Officer | -7,37k | 145,17k | Verkauf | 19,69 | 144,99k | -4,84% |
| 2026-01-31 | Dr. Mark P. SchoenbergChief Medical Officer | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 142,36k | 10,33% |
| 2025-11-26 | Dr. Stuart HoldenIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Ms. Cynthia Marie ButittaIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Mr. James A. RobinsonIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Dr. Leana S. WenIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Mr. Daniel G. WildmanIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-19 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 250,00k | Automatic Disposition | 25,00 | 139,03k | -6,71% |
| 2025-10-08 | Mr. Christopher DegnanCFO | 2,28k | 0,00 | Derivative Exercise and Retained Stock | - | 2,28k | - |
| 2025-10-08 | Mr. Christopher DegnanCFO | -2,20k | 37,12k | Derivative Exercise and Sale | 16,85 | 2,28k | - |
| 2025-09-07 | Dr. Mark P. SchoenbergChief Medical Officer | 796,00 | 0,00 | Derivative Exercise and Retained Stock | - | 149,03k | 0,54% |
| 2025-09-07 | Dr. Mark P. SchoenbergChief Medical Officer | -871,00 | 16,64k | Derivative Exercise and Sale | 19,11 | 149,03k | - |
| 2025-09-07 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 43,31k | 4,37% |
| 2025-09-07 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -1,52k | 29,05k | Derivative Exercise and Sale | 19,11 | 43,31k | - |
| 2025-08-11 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 176,90k | Verkauf | 17,69 | 148,23k | -6,32% |
| 2025-07-28 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -7,52k | 143,97k | Verkauf | 19,14 | 41,49k | -15,35% |
| 2025-07-28 | Dr. Mark P. SchoenbergChief Medical Officer | 4,85k | 0,00 | Derivative Exercise and Retained Stock | - | 158,23k | 3,16% |
| 2025-07-28 | Dr. Mark P. SchoenbergChief Medical Officer | -5,15k | 98,55k | Derivative Exercise and Sale | 19,14 | 158,23k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
